Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimers disease (AD)[1]. Azeliragon also can
Molecular Weight:
532.12
Purity:
99.70
CAS Number:
[603148-36-3]
Formula:
C32H38ClN3O2
Target:
Amyloid-beta
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted